Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension

Published:2019-10 Issue:4 Volume:9 Page:1-9
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Bouzina Habib¹²^ORCID,Hesselstrand Roger³⁴,Rådegran Göran¹²

Affiliation:

1. Section of CardiologyFaculty of MedicineLund UniversityLundSweden

2. The Hemodynamic LabSkåne University HospitalLundSweden

3. Section of Rheumatology, Faculty of MedicineLund UniversityLundSweden

4. Department of RheumatologySkåne University HospitalLundSweden

Funder

Actelion Pharmaceuticals

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894019895446

Reference41 articles.

1. Pathology of pulmonary hypertension;Tuder RM;Clin Chest Med,2007

2. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments;Zhao L;Circulation,2013

3. Alterations of cellular bioenergetics in pulmonary artery endothelial cells;Xu W;Proc Natl Acad Sci U S A,2007

4. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis;McMurtry MS;Circ Res,2004

5. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle;Piao L;J Mol Med (Berl),2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions;JHLT Open;2024-11

2. Risk stratification and treatment goals in pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

3. Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patients;Clinical and Experimental Medicine;2024-05-22

4. Adipokines in pulmonary hypertension: angels or demons?;Heliyon;2023-11

5. Mendelian Randomization Reveals the Role of HMGCR in Pulmonary Arterial Hypertension Treatment, Independent of LDL Cholesterol Concentration;2023-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3